Jean Zhao

22PUBLICATIONS
198CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursGlycobiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 20, 2026
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer.

|May 04, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

|Feb 27, 2026
Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

Xin Cheng, Changli Qian, Erica Holdridge

|Feb 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolution.

Sebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler

|Feb 18, 2026
Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Yubao Wang, Cherubin Manokaran, Yutian Zou

|Nov 14, 2025
PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis.

Shuang Tang, Qian Zhou, Johann S Bergholz

Pageof 4

Frequent Collaborators

6 joint publications

Johann S Bergholz

5 joint publications

Sheheryar Kabraji

3 joint publications

Hao Gu

3 joint publications

Thomas M Roberts